Is There Equity in Cancer Funding?

Nonprofit organization funding (NPO) and National Cancer Institute (NCI) stipends are crucial to support and sustain cancer research. However, not all cancer funding is equal. A recent study by Cleveland Clinic and the Taussig Cancer Institute set out to determine if the NCI and NPO revenue received corresponded to cancer incidences and mortality.

The results revealed that the following cancer types received the most funding, and also had the highest incidence: leukemia and lymphoma, breast cancer, and lung cancer. However, lung cancer research projects received eight times less funding than breast cancer or leukemia. Underfunded cancers included colorectal, endometrial, and liver cancer.

It is important to note that the amount of funding provided to a type of cancer was closely linked to the number of clinical trials for that cancer, the researchers reported.